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ABSTRACT: Airway instillation into rats of 2-chloroethyl ethyl sulfide (CEES), the half molecule of sulfur mustard
compound, results in acute lung injury, as measured by the leak of plasma albumin into the lung. Morphologically,
early changes in the lung include alveolar hemorrhage and fibrin deposition and the influx of neutrophils. Following lung
contact with CEES, progressive accumulation of collagen occurred in the lung, followed by parenchymal collapse. The co-
instillation with CEES of liposomes containing pegylated (PEG)-catalase (CAT), PEG-superoxide dismutase (SOD), or the
combination, greatly attenuated the development of lung injury. Likewise, the co-instillation of liposomes containing the
reducing agents, N-acetylcysteine (NAC), glutathione (GSH), or resveratrol (RES), significantly reduced acute lung injury.
The combination of complement depletion and airway instillation of liposomes containing anti-oxidant compounds
maximally attenuated CEES-induced lung injury by nearly 80%. Delayed airway instillation of anti-oxidant-containing
liposomes (containing NAC or GSH, or the combination) significantly diminished lung injury even when instillation was
delayed as long as 1 h after lung exposure to CEES. These data indicate that CEES-induced injury of rat lungs can be
substantially diminished by the presence of reducing agents or anti-oxidant enzymes delivered via liposomes. Copyright
© 2005 John Wiley & Sons, Ltd.
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Introduction
As is well known, mustard gas [bis (2-chloroethyl
ethyl) sulfide], also known as sulfur mustard (HD),
has long been known to be a vesicant in humans
and, when inhaled, causes extreme lung damaging re-
actions (Eisenmenger et al., 1991; Khateri et al., 2003;
Lakshmana Rao et al., 1999). In human survivors, pro-
gressive lung dysfunction due to pulmonary fibrosis is
well documented (Emad and Rezaian, 1999). Not unex-
pectedly, HD is radiomimetic, teratogenic and mutagenic
(Angelov et al., 1996; Dube et al., 1998). Currently, there
is no effective therapy for either the vesicant-inducing
properties of HD or for the outcomes that can lead to
acute and progressive lung injury and death.
2-Chloroethyl ethyl sulfide (CEES) is less toxic
than HD and can be used in the absence of facilities
required for HD studies. In rats CEES has been shown
to induce acute lung injury in a dose-dependent and
time-dependent manner (McClintock et al., 2002). CEES-
induced acute lung injury is complement- and neutrophil-
dependent, suggesting that some of the CEES-induced
injury is due to engagement of the inflammatory response
in lung in an unknown manner (McClintock et al., 2002).
Furthermore, lung injury is attenuated after intravenous
treatment with the anti-oxidant, N-acetylcysteine (NAC),
or airway delivery of anti-oxidants or anti-oxidant
enzymes (McClintock et al., 2002). These data have sug-
gested that CEES compromises the redox potential in the
lung, putting it at risk of oxidant-mediated injury.
Liposomal delivery of drugs or chemical compounds
is a way to achieve high tissue levels of a desired
compound (Fan et al., 2000; Freeman et al., 1985;
Suntres and Shek, 1996). In the lung, airway delivery of
liposomes results in macrophage uptake of liposomes by
a phagocytic pathway (Gonzalez-Rothi et al., 1991;
Shephard et al., 1981; Sone et al., 1980). As far as is
known, liposomes are not internalized by any other lung
cells. The current studies demonstrated that liposomes
containing anti-oxidants or anti-oxidant enzymes cause
a reduction in acute lung injury in rats following
airway delivery of CEES. Furthermore, delivery of such
liposomes, when delayed 1 h after CEES administration,
still provides significant attenuation of acute lung injury.
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These findings may have important therapeutic implica-
tions for HD-induced acute lung injury in humans.
Materials and Methods
Chemicals
Except where noted, all chemicals and reagents were
purchased from the Sigma Chemical Co. (St Louis, MO).
Animal Model
Adult male (275–325 g) specific pathogen-free Long-
Evans rats (Harlan Co., Indianapolis, IN) were used
in these studies. Intraperitoneal ketamine (100 mg kg−1
body weight) (Fort Dodge Animal Health, Fort Dodge,
IA) was used for anesthesia and intraperitoneal xylazine
(13 mg kg−1 body weight) (Bayer Corp. Shawnee Mission,
KS) was used for sedation when required (delayed time
point liposome administration). The experimental proce-
dure for CEES-induced lung injury in rats has been
described previously (McClintock et al., 2002). Briefly,
after induction of anesthesia, 125I-labeled bovine serum
albumin (125I-BSA, 0.5 µCi per rat) was injected intra-
venously as a quantitative marker for vascular leakage.
The trachea was then surgically exposed and a slightly
curved P50 catheter was inserted into the trachea past the
bifurcation so as to facilitate a unilateral, left-lung injury.
A small volume of CEES (2 µl per rat; about 6 mg kg−1)
was solubilized in ethanol (58 µl per rat) and then added
to a syringe containing Dulbecco’s phosphate buffered
saline (DPBS) (340 µl per rat). This solution was injected
via the intratracheal catheter, into the left lung main stem
bronchus. Studies, not requiring the usage of a radio-
labeled marker, proceeded identically substituting DPBS
for the radioactive injection. For all studies, except the
time response experiment, animals were killed 4 h later,
the pulmonary arterial circulation was flushed with 10 ml
of cold DPBS, the lungs were surgically dissected, placed
in counting vessels, and the amount of radioactivity
(125I-labeled BSA) determined by gamma counting. For
calculations of the permeability index, the amount of
radioactivity (125I-labeled BSA) remaining in the lungs
in which the vasculature was perfused with saline was
divided by the amount of radioactivity present in 1.0 ml
of blood obtained from the inferior vena cava at the
time of killing as described elsewhere (McClintock
et al., 2002). 125I-BSA present in the lung after thorough
flushing of the vasculature is a quantitative measure of
the degree of vascular endothelial and alveolar epithelial
damage, in which much of the 125I-BSA can be lavaged
from the distal airway compartment, indicating the loss
of the vascular and epithelial barriers (Johnson and
Ward, 1974).
All animal experiments were in accordance with the
standards in The Guide for the Care and Use of Labora-
tory Animals, and were supervised by veterinarians from
the Unit for Laboratory and Animal Care of the Univer-
sity of Michigan Medical School.
Complement Depletion
Cobra venom factor (CVF) was purified from crude,
lyophilized cobra venom (Naja atra) by ion exchange
chromatography (Ballow and Cochrane, 1969). Com-
plement depletion of experimental animals was achieved
by intraperitoneal injections of 25 units of CVF per rat at
time zero and 24 h later, resulting in undetectable levels
of serum hemolytic complement activity as confirmed by
CH50 assay (Mayer, 1961). Experiments were performed
24 h after the second CVF injection.
Liposome Preparation
Dipalmitoylphosphatidylcholine (DPPC, Avanti Polar
Lipids) was dissolved 20 mg ml−1 in a 2 : 1 v/v chloro-
form/methanol solution. When α-tocopherol (αT) was
also included in the liposomes, it was added just after
the chloroform/methanol solvent to provide a 7 : 3 molar
ratio (DPCC : α-T) after first being carefully dissolved in
a small volume of ethanol. The DPPC or (DPPC : α-T)
solution was then dried under a thin stream of nitrogen
in a round bottom flask to form a thin lipid film on
the walls of the tube. Once the film had been dried, the
tube was then placed on a vacuum for at least 1 h to
further dry and remove any excess organic compounds
from the lipid film.
The compounds being encapsulated in the liposomes
were exclusively prepared in Dulbecco’s phosphate buff-
ered saline (DPBS), pH adjusted to 7.4 and then added to
the lipid film. The tube was then vortexed to free the
lipid film from the walls of the tube, and then placed in
a heated water bath (41 °C). When sizing the liposomes,
it is necessary to keep them at a temperature above their
transition phase. The transition phase temperature for
DPPC is 41 °C. Vortexing the liposomes once they are
above the transition phase temperature results in large
multilamellar vesicles. To reduce the size of the vesicles
and to produce uniform small unilamellar vesicles, the
lipid suspension was then passed ten times through poly-
carbonate membrane filters in a Liposofast Basic mini
extruder available from Avestin, Inc. (Ottawa, Ontario).
The resulting liposomes were uniform in size measuring
100 nm in diameter. According to the manufacturer, the
use of an extruder is an efficient method for producing
liposomes that are of relatively uniform size. Liposomes
were checked via light microscopy for uniformity and
size. Liposomes were injected intratracheally in a volume
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of 100 µl per rat through the same catheter setup used for
CEES instillation at the time point designated by each
individual experimental protocol.
Morphological Assessment of Lung Injury
In order morphologically to assess lung injury, lungs
were fixed by intratracheal instillation of 10 ml buffered
(pH 7.2) formalin (10%) at the indicated time points
following airway instillation of CEES. Lung sections
were then obtained for histological examination by stain-
ing with hematoxylin and eosin. In addition, lung sections
were stained with trichrome in order to assess the
deposition of fibrin and collagen (Luna, 1968).
Statistical Analysis
The results are presented as mean ± SEM in the text
and figures. Groups (n ≥ 5) were subjected to one-
way analysis of variance and when significance was
found, Student’s t-test with the Bonferroni correction for
multiple comparisons was applied. A value of P < 0.05
was considered significant.
Results
Histopathologic Features of Lung Response
to CEES
Following airway instillation of CEES into rat lungs,
tissues were obtained at 0, 6, 12 and 24 h as well 3
and 6 days and 6 weeks after exposure to CEES. Lung
sections were stained with trichrome stain to evaluate
lung deposition of fibrin and collagen. Composite results
are shown in Fig. 1 (frames A–I). At time 0, trichrome
stains revealed the usual perivascular and septal evidence
of collagen (frames A, B). As early as 6 h, increased
evidence of trichrome stained deposition in alveolar
walls was likely related to fibrin deposition (frame C). By
24 h after lung instillation of CEES, dense interstitial and
intra-alveolar accumulations of trichrome positive (blue
dye) were evident throughout the affected lungs, sugges-
tive of increased deposition of fibrin and collagen fibers
(frame D). Intra-alveolar hemorrhage, edema and intra-
alveolar accumulation of macrophages and mononuclear
cells were found at 24 h (frame E). By 3 days, dense
interstitial deposits of fibrin and collagen occurred (frame
F). By day 6, extensive confluent collagen deposits were
found in the lung, together with a collapse of alveolar
Figure 1. Tissue sections of lungs with trichrome stain. Lungs were obtained after airway instillation of CEES at
time 0 (A, B, 10× and 40×); 6 h (C, 40×); 24 h (D, E, 10× and 40×); 3 days (F, 10×), 6 days (G, 10× and H, 40×); and
3 weeks (I, 40×). All tissue sections were reacted with trichrome stain
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Figure 2. Attenuative effects of liposomes loaded
with anti-oxidant enzymes. Rats received either saline
followed by unloaded liposomes (negative control),
CEES followed by airway delivery of unloaded lipo-
somes (positive control), or CEES with liposomes
containing either pegylated (PEG)-CAT or PEG-SOD,
individually or the combination, or the combination
of liposomes in complement depleted animals induced
by the earlier intraperitoneal injection of purified
cobra venom factor. Liposomes were administered
immediately after CEES instillation. For each bar n ≥ 6.
Lung injury values are represented by the leak of 125I-
albumin from the vascular compartment into the
airway compartment 4 h after airway delivery of CEES
(see text). * Represents P values of <0.05 when com-
pared with the positive control group
structures and the appearance of honeycombing (frames
G, H). By week 3, little recognizable lung structure
remained in the face of dense collagen deposits and
parenchymal collapse, together with numerous interstitial
macrophages and mononuclear cells (frame I).
Attenuation of CEES-Induced Acute Lung Injury
by Anti-Oxidant Enzymes in Liposomes
As shown in Fig. 2, the airway instillation of CEES
together with unloaded liposomes resulted 4 h later in
approximately a 10-fold increase in lung injury, as
defined by the leakage of 125I-albumin from blood into
the lung. When instilled into the lung immediately
after CEES, polyethyleneglycol (PEG)-linked catalase-
containing liposomes (LIP-PEG-CAT) attenuated injury
by 40%. Liposomes containing PEG-superoxide dismutase
(PEG-SOD) diminished injury by 57%. The combination
of PEG-SOD and PEG-CAT in liposomes further reduced
injury by 71%. With the combination of PEG-SOD
and PEG-CAT liposomes given to complement-depleted
animals, the injury was reduced by 86%. These data
indicate that anti-oxidant enzymes have powerful
attenuative effects on CEES-induced acute lung injury.
Since, as described above, airway delivery of liposomes
results in their phagocytosis by lung macrophages, it
seems likely that the attenuative effects of liposomes
Figure 3. Attenuative effects of liposomes loaded
with reducing agents in CEES lung injury. The positive
and negative controls are similar to those described
in Fig. 1. When used, liposomes were injected intra-
tracheally immediately after the airway instillation of
CEES. Lung injury was determined by the permeability
index. αT, α-tocopherol
containing anti-oxidant enzymes are due to the bolstering
of anti-oxidant defenses in lung macrophages.
Attenuative Effects of Liposomes Containing
Reducing Agents
In an additional set of experiments (shown in Fig. 3),
there was approximately a 10-fold increase in leakage of
albumin from the circulation into the lungs of animals
receiving airway instillation of CEES 4 h earlier together
with unloaded liposomes. When liposomes containing
NAC (Lip-NAC) were instilled immediately after CEES,
injury was attenuated by 60%. Liposomes containing
glutathione (GSH) led to a 48% reduction in lung injury.
Liposomes containing α-tocopherol (αT) reduced injury
by 37%. Liposomes containing the reducing agent present
in red wine, resveratrol (RES), reduced injury by 48%,
while liposomes containing PEG-CAT reduced injury by
44%. These data indicate that reducing agents presented
in liposomes have significantly attenuative effects against
CEES-induced acute lung injury. The data also indicate
that the non-derivatized form of catalase (CAT) also has
attenuative effects when given within liposomes.
Additive Effects of Complement Depletion and
Liposomes Containing Reducing Agents
Previous studies in our laboratory have shown that
complement depletion resulted in a 43% reduction
of lung injury (McClintock et al., 2002). As shown in
Fig. 4, approximately a 10-fold increase in the leakage of
125I-albumin into the lungs occurred following instillation
of CEES together with unloaded liposomes. When the
animals were complement (C) depleted, the instillation
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Figure 4. Enhanced effects of anti-oxidant containing
liposomes in complement depleted rats. The negative
and positive control groups are similar to those de-
scribed in Fig. 1. Complement depletion was induced
in four groups of animals by the prior intraperitoneal
injection of purified cobra venom factor (CVF). Lipo-
somes containing the various anti-oxidant compounds
were given immediately after airway instillation of
CEES. For each group, n ≥ 6
of liposomes containing NAC reduced injury by 79%,
those containing GSH reduced injury by 72% in
complement-depleted rats, liposomes containing the
combination of NAC and GSH reduced injury by 78% in
complement-depleted rats. Complement-depleted animals
receiving liposomes containing αT together with GSH
showed an 82% reduction in lung injury as measured by
leakage of albumin from the blood. Thus, the combina-
tion of complement depletion and anti-oxidant liposomes
seems significantly to attenuate CEES-induced acute lung
injury in an additive manner.
Effects of Delayed Lung Instillation of
Anti-Oxidant Liposomes
As shown in Fig. 5, in CEES treated animals instillation
of liposomes containing reducing agents was done either
10 min before the airway instillation of CEES or at 30,
60 and, in one case, 90 min following the airway instilla-
tion of CEES. As shown in Fig. 5, over the course of the
first 60 min after instillation of CEES, there were sig-
nificant attenuative effects of liposomes containing NAC
or GSH, or the combination. Under these circumstances,
injury was reduced between 55% and 77%, respectively.
In the case of liposomes containing the combination
of NAC and GSH, even when delivery was delayed
until 90 min following instillation of CEES, there was a
55% reduction in the development of acute lung injury.
These data indicate that delayed airway administration
of anti-oxidant-containing liposomes results in significant
reduction of CEES-induced lung injury, even when
delivery is delayed by at least an hour following exposure
of lungs to CEES.
Figure 5. Attenuative effects of anti-oxidant contain-
ing liposomes when airway instillation was given at
various time points before or after airway delivery
of CEES. The dotted line near the top represents the
positive control value. Lung injury values (permeability
indices) in the negative control are not shown but
were <0.5, as described in Figs 1–3
Discussion
The data described in this report indicate that CEES
instillation into the lung produces acute lung injury in
a manner that seems related to the loss of the redox
balance in the lung, although this has not been demon-
strated directly. This conclusion is based on the
attenuative effects of reducing agents (NAC, GSH, αT,
resveratrol) or anti-oxidant enzymes (SOD, CAT) or
various combinations, all presented in liposomes alone or
in combination. Since it is well known that liposomes
given into the airways are phagocytized by macrophages
and internalized (Gonzalez-Rothi et al., 1991; Lentsch
et al., 1999; Shephard et al., 1981), the implications from
the current studies are that liposomal delivery selectively
enhances a reducing environment in lung macrophages,
which may be compromised when these cells came into
contact with CEES.
The morphological features described in this report
are consistent with our earlier report of an accumula-
tion of myeloperoxidase (MPO) in the lung after CEES
instillation (McClintock et al., 2002). The presence of
alveolar hemorrhage and edema implies a severe dis-
ruption of vascular and distal airway barrier. These
changes are consistent with the concept that CEES
induces an acute lung-damaging inflammatory response
that is complement-dependent. Beneficial effects of
neutrophil and complement depletion as demonstrated
previously indicate that the inflammatory response to
CEES contributes to the development of lung injury
(McClintock et al., 2002). Masson’s trichrome staining
revealed an accumulation of fibrin and/or collagen within
the alveolar spaces. Deposition of fibrin reflects a non-
specific reaction to tissue damage. It remains to be shown
ANTI-OXIDANT LIPOSOMES AND ACUTE LUNG INJURY 131
Copyright © 2005 John Wiley & Sons, Ltd. J. Appl. Toxicol. 2006; 26: 126–131
that CEES-exposure causes rapid development of inter-
stitial fibrosis, as confirmed biochemically by collagen
accumulation. It is hypothesized that epithelial and endo-
thelial damage following CEES-exposure results in dis-
ruption of tissues, resulting in collagen accumulation in
the interstitial and alveolar spaces. It appears likely that
following lung exposure to CEES collagen deposition
occurs in a widespread manner, resulting in parenchymal
collapse and the honeycombing changes that occur in
humans with pulmonary fibrosis. Numerous macrophages
and mononuclear cells in areas of collagen deposition
in the lung may be associated with the release of medi-
ators (such as TGFβ) that promote lung production of
collagen.
How CEES functions as a powerful oxidant and what
lung cells are targets of CEES is unclear. The extensive
leakage of albumin into the lung after exposure to airway
administration of CEES infers that the blood–gas barrier
has been seriously compromised, causing a functional
impairment (or destruction) of both vascular endothelial
and alveolar epithelial cells. The subsequent alveolar
flooding with plasma components leaking into the distal
airway compartment could seriously compromise blood–
gas exchange, resulting in hypoxia.
The permeability index after instillation of CEES
and empty liposomes was found to be similar to CEES
instillation alone (as reported in McClintock et al., 2002)
implying that empty liposomes do not cause any lung
damage by themselves. The fact that the combination of
complement depletion and liposomal delivery of GSH
or NAC enhances the attenuation when compared with
the use of either type of liposomes given to complement-
intact rats (Figs 3 and 4) suggests that it may be both the
loss of reducing potential in the lung as well as an en-
gagement of complement activation products (e.g. C5a)
that leads to intense acute lung injury. Whether com-
plement activation products are directly responsible for
lung injury or are functioning to enhance cytokine and
chemokine expression remains to be determined. In a
recent study it was shown that neutrophil depletion prior
to CEES delivery was also capable of reducing CEES-
induced lung injury (McClintock et al., 2002), suggesting
that activated neutrophils enter into the sequence of
destructive events after CEES instillation into the lung.
A matter of considerable interest is that delayed
delivery (for as long as 60 min) of liposomes containing
NAC or GSH, or the combination, into lungs after CEES
instillation still provides substantial attenuation from the
massive leak of albumin into the lung. It should be noted
that there is not much increased albumin leak into the
lung in the first 60 min after administration of CEES
(McClintock et al., 2002). In fact, compared with values
at 1 h, the permeability index at 2, 4 and 6 h after in-
stillation of CEES rose 2 fold, 2.9 fold, 7.7 fold and 16.2
fold, respectively, when compared with uninjured lung
values. Accordingly, the development of extensive lung
injury after airway instillation of CEES requires con-
siderable time for full development of lung injury. This
would be in accord with the concept that CEES triggers
in the lung an acute inflammatory response, which itself
serves to cause lung damage. Since this sequence requires
several hours before the large increases in lung perme-
ability (albumin leak into lung) are seen, this may explain
why delayed administration of anti-oxidant liposomes can
still bring about significant attenuative effects. Under-
standing more fully the molecular events that lead to
CEES-induced intense acute lung injury may provide
even better strategies for effective therapeutic intervention
after exposure of lung to HD and related compounds.
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